Timothy Daley
Stock Analyst at Wells Fargo
(2.64)
# 1,935
Out of 4,828 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $41.86 | +11.51% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $3.89 | +414.14% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $91.25 | +4.11% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $37.52 | +91.90% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $106.93 | +35.60% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,080.98 | +20.26% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $344.06 | -17.17% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $189.73 | +30.19% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $138.79 | +98.14% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $245.73 | +9.88% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.97 | +369.01% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $24.00 | +45.83% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $403.13 | +28.99% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.96 | +359.18% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $123.20 | +50.17% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $56.75 | +49.78% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $148.99 | +47.66% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $133.96 | +64.23% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $12.02 | +132.95% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $176.96 | -20.89% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $49.94 | +80.22% | 3 | Jan 10, 2023 | |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $41.86
Upside: +11.51%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $3.89
Upside: +414.14%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $91.25
Upside: +4.11%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $37.52
Upside: +91.90%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $106.93
Upside: +35.60%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,080.98
Upside: +20.26%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $344.06
Upside: -17.17%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $189.73
Upside: +30.19%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $138.79
Upside: +98.14%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $245.73
Upside: +9.88%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.97
Upside: +369.01%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $24.00
Upside: +45.83%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $403.13
Upside: +28.99%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.96
Upside: +359.18%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $123.20
Upside: +50.17%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $56.75
Upside: +49.78%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $148.99
Upside: +47.66%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $133.96
Upside: +64.23%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $12.02
Upside: +132.95%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $176.96
Upside: -20.89%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $49.94
Upside: +80.22%